Potent inhibition of simian immunodeficiency virus (SIV) replication by an SIV-based lentiviral vector expressing antisense Env. 2007

Stephen E Braun, and Xiaobin V Lu, and Fay Eng Wong, and Michelle Connole, and Gang Qiu, and Ziping Chen, and Tatiana Slepushkina, and Vladimir Slepushkin, and Laurent M Humeau, and Boro Dropulic, and R Paul Johnson
Division of Immunology, New England Primate Research Center, Harvard Medical School, Southborough, MA 01772, USA. stephen_braun@hms.harvard.edu

In light of findings demonstrating that the macaque TRIM5alpha protein inhibits infection of cells by human immunodeficiency virus (HIV)-1, simian immunodeficiency virus (SIV)-based lentiviral vectors may have distinct advantages over HIV-1 vectors for the transduction of macaque hematopoietic stem cells. We evaluated the ability of an SIV vector (VRX859) encoding an antisense SIV envelope sequence and enhanced green fluorescent protein (GFP) to inhibit viral replication and to transduce rhesus CD34(+) lymphoid progenitor cells. After infection with homologous SIV strains, CD4(+) cell lines transduced with VRX859 exhibited more than 600-fold inhibition of viral replication compared with control cells. Less inhibition was observed with the divergent SIV strain SIVsmE660. Partial inhibition of a chimeric simian-human immunodeficiency virus, which contains an HIV-1 envelope in an SIV backbone, was observed, suggesting that the SIV vector also contributes to viral inhibition independent of the antisense envelope inhibitor. Transduction of rhesus CD34(+) cells with VRX859 at various multiplicities of infection resulted in transduction efficiencies comparable to those obtained with the HIV vector VRX494. However, when we evaluated transduction of rhesus T lymphocyte progenitors by examining GFP expression in CD4(+) T cells derived from transduced CD34(+) cells, we observed more efficient transduction with the SIV-based vector. GFP(+)CD4(+) T cells derived from VRX859-transduced CD34(+) cells strongly inhibited SIVmac239 replication as compared with control CD4(+) T cells. The ability of this SIV-based vector to mediate potent inhibition of SIV replication, coupled with its efficient transduction of rhesus hematopoietic progenitor cells, make it an important candidate for proof-of-principle experiments of stem cell gene therapy in the SIV-macaque model.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D005456 Fluorescent Dyes Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. Flourescent Agent,Fluorescent Dye,Fluorescent Probe,Fluorescent Probes,Fluorochrome,Fluorochromes,Fluorogenic Substrates,Fluorescence Agents,Fluorescent Agents,Fluorogenic Substrate,Agents, Fluorescence,Agents, Fluorescent,Dyes, Fluorescent,Probes, Fluorescent,Substrates, Fluorogenic
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D014161 Transduction, Genetic The transfer of bacterial DNA by phages from an infected bacterium to another bacterium. This also refers to the transfer of genes into eukaryotic cells by viruses. This naturally occurring process is routinely employed as a GENE TRANSFER TECHNIQUE. Genetic Transduction,Genetic Transductions,Transductions, Genetic

Related Publications

Stephen E Braun, and Xiaobin V Lu, and Fay Eng Wong, and Michelle Connole, and Gang Qiu, and Ziping Chen, and Tatiana Slepushkina, and Vladimir Slepushkin, and Laurent M Humeau, and Boro Dropulic, and R Paul Johnson
September 2000, Human gene therapy,
Stephen E Braun, and Xiaobin V Lu, and Fay Eng Wong, and Michelle Connole, and Gang Qiu, and Ziping Chen, and Tatiana Slepushkina, and Vladimir Slepushkin, and Laurent M Humeau, and Boro Dropulic, and R Paul Johnson
April 2002, Gene therapy,
Stephen E Braun, and Xiaobin V Lu, and Fay Eng Wong, and Michelle Connole, and Gang Qiu, and Ziping Chen, and Tatiana Slepushkina, and Vladimir Slepushkin, and Laurent M Humeau, and Boro Dropulic, and R Paul Johnson
June 2002, Human gene therapy,
Stephen E Braun, and Xiaobin V Lu, and Fay Eng Wong, and Michelle Connole, and Gang Qiu, and Ziping Chen, and Tatiana Slepushkina, and Vladimir Slepushkin, and Laurent M Humeau, and Boro Dropulic, and R Paul Johnson
January 1990, Journal of medical primatology,
Stephen E Braun, and Xiaobin V Lu, and Fay Eng Wong, and Michelle Connole, and Gang Qiu, and Ziping Chen, and Tatiana Slepushkina, and Vladimir Slepushkin, and Laurent M Humeau, and Boro Dropulic, and R Paul Johnson
August 1994, Journal of medical primatology,
Stephen E Braun, and Xiaobin V Lu, and Fay Eng Wong, and Michelle Connole, and Gang Qiu, and Ziping Chen, and Tatiana Slepushkina, and Vladimir Slepushkin, and Laurent M Humeau, and Boro Dropulic, and R Paul Johnson
August 1998, Journal of virology,
Stephen E Braun, and Xiaobin V Lu, and Fay Eng Wong, and Michelle Connole, and Gang Qiu, and Ziping Chen, and Tatiana Slepushkina, and Vladimir Slepushkin, and Laurent M Humeau, and Boro Dropulic, and R Paul Johnson
August 2012, Retrovirology,
Stephen E Braun, and Xiaobin V Lu, and Fay Eng Wong, and Michelle Connole, and Gang Qiu, and Ziping Chen, and Tatiana Slepushkina, and Vladimir Slepushkin, and Laurent M Humeau, and Boro Dropulic, and R Paul Johnson
August 1990, Virology,
Stephen E Braun, and Xiaobin V Lu, and Fay Eng Wong, and Michelle Connole, and Gang Qiu, and Ziping Chen, and Tatiana Slepushkina, and Vladimir Slepushkin, and Laurent M Humeau, and Boro Dropulic, and R Paul Johnson
March 2000, Journal of virology,
Stephen E Braun, and Xiaobin V Lu, and Fay Eng Wong, and Michelle Connole, and Gang Qiu, and Ziping Chen, and Tatiana Slepushkina, and Vladimir Slepushkin, and Laurent M Humeau, and Boro Dropulic, and R Paul Johnson
October 2010, Transgenic research,
Copied contents to your clipboard!